BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bernardo A, De Nuccio C, Visentin S, Martire A, Minghetti L, Popoli P, Ferrante A. Myelin Defects in Niemann-Pick Type C Disease: Mechanisms and Possible Therapeutic Perspectives. Int J Mol Sci 2021;22:8858. [PMID: 34445564 DOI: 10.3390/ijms22168858] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Agrawal I, Lim YS, Ng S, Ling S. Deciphering lipid dysregulation in ALS: from mechanisms to translational medicine. Transl Neurodegener 2022;11:48. [DOI: 10.1186/s40035-022-00322-0] [Reference Citation Analysis]
2 Passarella D, Ronci M, Di Liberto V, Zuccarini M, Mudò G, Porcile C, Frinchi M, Di Iorio P, Ulrich H, Russo C. Bidirectional Control between Cholesterol Shuttle and Purine Signal at the Central Nervous System. IJMS 2022;23:8683. [DOI: 10.3390/ijms23158683] [Reference Citation Analysis]
3 Kubaski F, Burlina A, Polo G, Pereira D, Herbst ZM, Silva C, Trapp FB, Michelin-Tirelli K, Lopes FF, Burin MG, Brusius-Facchin AC, Netto ABO, Faqueti L, Iop GD, Poletto E, Giugliani R. Experience of the NPC Brazil Network with a Comprehensive Program for the Screening and Diagnosis of Niemann-Pick Disease Type C. Int J Neonatal Screen 2022;8. [PMID: 35892469 DOI: 10.3390/ijns8030039] [Reference Citation Analysis]
4 Boussadia Z, Chiodi V, Pazienti A, Martire A. A major role for adenosine A2A receptor in the interaction between astrocytes and myelinated neurons: possible implications for the therapy of neurodegenerative disorders. Purinergic Signal 2022. [PMID: 35066787 DOI: 10.1007/s11302-021-09835-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]